Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life

Alfonso Fasano; L Ricciardi; F Lena; Anna Rita Bentivoglio; Nicola Modugno

Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life

Alfonso Fasano^*, L Ricciardi, F Lena, Anna Rita Bentivoglio, Nicola Modugno

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

36 Citazioni (Scopus)

Abstract

Continuous infusion of intrajejunal levodopa/carbidopa gel (CIILG) for advanced Parkinson's disease (PD) has been proved to be beneficial on motor complications, non-motor symptoms and quality of life in the short-term follow-up. Aim of this two-center, retrospective, open-label study was to evaluate the long-term effect of CIILG on patients' condition and caregivers' quality of life.

Lingua originale	Inglese
pagine (da-a)	79-89
Numero di pagine	11
Rivista	European Review for Medical and Pharmacological Sciences
Volume	16
Numero di pubblicazione	1
Stato di pubblicazione	Pubblicato - 2012

All Science Journal Classification (ASJC) codes

Farmacologia (medica)

Keywords

Adult
Aged
Antiparkinson Agents
Caregivers
Cohort Studies
Disability Evaluation
Female
Humans
Infusions
Jejunum
Levodopa
Male
Middle Aged
Neuropsychological Tests
Parenteral
Parkinson Disease
Quality of Life
Retrospective Studies
Treatment Outcome

Altri file e collegamenti

Cita questo

@article{fb44d588d1b64de7bee5eac36b3fbf44,

title = "Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life",

abstract = "Continuous infusion of intrajejunal levodopa/carbidopa gel (CIILG) for advanced Parkinson's disease (PD) has been proved to be beneficial on motor complications, non-motor symptoms and quality of life in the short-term follow-up. Aim of this two-center, retrospective, open-label study was to evaluate the long-term effect of CIILG on patients' condition and caregivers' quality of life.",

keywords = "Adult, Aged, Antiparkinson Agents, Caregivers, Cohort Studies, Disability Evaluation, Female, Humans, Infusions, Jejunum, Levodopa, Male, Middle Aged, Neuropsychological Tests, Parenteral, Parkinson Disease, Quality of Life, Retrospective Studies, Treatment Outcome, Adult, Aged, Antiparkinson Agents, Caregivers, Cohort Studies, Disability Evaluation, Female, Humans, Infusions, Jejunum, Levodopa, Male, Middle Aged, Neuropsychological Tests, Parenteral, Parkinson Disease, Quality of Life, Retrospective Studies, Treatment Outcome",

author = "Alfonso Fasano and L Ricciardi and F Lena and Bentivoglio, \{Anna Rita\} and Nicola Modugno",

year = "2012",

language = "English",

volume = "16",

pages = "79--89",

journal = "European Review for Medical and Pharmacological Sciences",

issn = "1128-3602",

publisher = "Verduci Editore s.r.l",

number = "1",

}

Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life. / Fasano, Alfonso; Ricciardi, L; Lena, F et al.
In: European Review for Medical and Pharmacological Sciences, Vol. 16, N. 1, 2012, pag. 79-89.

Risultato della ricerca: Contributo in rivista › Articolo

TY - JOUR

T1 - Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life

AU - Fasano, Alfonso

AU - Ricciardi, L

AU - Lena, F

AU - Bentivoglio, Anna Rita

AU - Modugno, Nicola

PY - 2012

Y1 - 2012

N2 - Continuous infusion of intrajejunal levodopa/carbidopa gel (CIILG) for advanced Parkinson's disease (PD) has been proved to be beneficial on motor complications, non-motor symptoms and quality of life in the short-term follow-up. Aim of this two-center, retrospective, open-label study was to evaluate the long-term effect of CIILG on patients' condition and caregivers' quality of life.

AB - Continuous infusion of intrajejunal levodopa/carbidopa gel (CIILG) for advanced Parkinson's disease (PD) has been proved to be beneficial on motor complications, non-motor symptoms and quality of life in the short-term follow-up. Aim of this two-center, retrospective, open-label study was to evaluate the long-term effect of CIILG on patients' condition and caregivers' quality of life.

KW - Adult

KW - Aged

KW - Antiparkinson Agents

KW - Caregivers

KW - Cohort Studies

KW - Disability Evaluation

KW - Female

KW - Humans

KW - Infusions

KW - Jejunum

KW - Levodopa

KW - Male

KW - Middle Aged

KW - Neuropsychological Tests

KW - Parenteral

KW - Parkinson Disease

KW - Quality of Life

KW - Retrospective Studies

KW - Treatment Outcome

KW - Adult

KW - Aged

KW - Antiparkinson Agents

KW - Caregivers

KW - Cohort Studies

KW - Disability Evaluation

KW - Female

KW - Humans

KW - Infusions

KW - Jejunum

KW - Levodopa

KW - Male

KW - Middle Aged

KW - Neuropsychological Tests

KW - Parenteral

KW - Parkinson Disease

KW - Quality of Life

KW - Retrospective Studies

KW - Treatment Outcome

UR - https://publicatt.unicatt.it/handle/10807/27259

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84859862768&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84859862768&origin=inward

M3 - Article

SN - 1128-3602

VL - 16

SP - 79

EP - 89

JO - European Review for Medical and Pharmacological Sciences

JF - European Review for Medical and Pharmacological Sciences

IS - 1

ER -

Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Altri file e collegamenti

Fingerprint

Cita questo